UBS Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $10.4K | Buy |
|
|||||
|
2024
Q3 | $36K | Sell |
|
|||||
|
2024
Q2 | $111K | Buy |
|
|||||
|
2024
Q1 | $112 | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $4.32K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $0 | Sell |
|
|||||
|
2022
Q2 | $1K | Buy |
|
|||||
|
2022
Q1 | $1K | Sell |
|
|||||
|
2021
Q4 | $87K | Buy |
|
|||||
|
2021
Q3 | $21K | Sell |
|
|||||
|
2021
Q2 | $73K | Buy |
|
|||||
|
2021
Q1 | $25K | Sell |
|
|||||
|
2020
Q4 | $140K | Buy |
|
|||||
|
2020
Q3 | $55K | Sell |
|
|||||
|
2020
Q2 | $139K | Sell |
|
|||||
|
2020
Q1 | $99K | Sell |
|
|||||
|
2019
Q4 | $307K | Buy |
|
|||||
|
2019
Q3 | $235K | Buy |
|
|||||
|
2019
Q2 | $53K | Buy |
|
|||||
|
2019
Q1 | $46K | Buy |
|
|||||
|
2018
Q4 | $14K | Sell |
|
|||||
|
2018
Q3 | $144K | Buy |
|
|||||
|
2018
Q2 | $69K | Buy |
|
|||||
|
2018
Q1 | $34K | Sell |
|
|||||
|
2017
Q4 | $35K | Buy |
|
|||||
|
2017
Q3 | $16K | Buy |
|
|||||
|
2017
Q2 | $13K | Buy |
|
|||||
|
2017
Q1 | $12K | Sell |
|
|||||
|
2016
Q4 | $12K | Buy |
|